Cytidine
Cytidine is a pyrimidine nucleoside (cytosine + ribose). Standalone oral cytidine is largely deaminated to uridine in the human gut before absorption — so free cytidine supplements raise plasma uridine more than cytidine. For brain effects (membrane phosphatidylcholine synthesis, cognition, stroke recovery research), the practical bioavailable form is citicoline (CDP-choline), not free cytidine. If you've found a 'cytidine' nootropic, the citicoline page on Pilora is the one with real RCT evidence.
Quick decision guide
May help most
Most users will get more out of citicoline (CDP-choline) than free cytidine. Cytidine itself has weak human evidence as a standalone supplement.
Common dosing range
Free cytidine supplement doses range 250–500 mg/day on the market, but evidence is thin. Citicoline trials used 250–2000 mg/day depending on indication. There is no established RDA — cytidine is not an essential nutrient.
When to expect effects
Citicoline cognitive trials measured outcomes over 4 weeks (attention) to 6+ months (vascular cognitive impairment). Free-cytidine standalone benefit is not reliably demonstrated.
Watch out for
Avoid combining with caffeine + theophylline (theoretical adenosine-pathway concerns from related nucleosides). Pregnancy data limited. Don't substitute for stroke or dementia therapy — citicoline's largest trial (ICTUS 2012) in stroke was negative.
Evidence snapshot
What is it
Cytidine is a pyrimidine nucleoside (cytosine attached to ribose). In supplements it appears as cytidine or cytidine 5'-monophosphate (CMP), often as a precursor to brain phospholipids.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
Cognitive impairment (vascular type, via citicoline) Limited Evidence | Modest pooled effect favoring citicoline 500–2000 mg/day for 6+ months in vascular cognitive impairment | Adults with mild vascular cognitive impairment exploring citicoline alongside vascular risk-factor management | 6+ months in vascular cognitive impairment trials |
Attention and focus in healthy adults (via citicoline) Limited Evidence | Small attention-task improvement at 250–500 mg citicoline daily over 4 weeks | Adults experimenting with citicoline for focus alongside sleep, caffeine, and other established strategies | Weeks |
Acute ischemic stroke recovery (via citicoline) Mixed Evidence | No significant benefit on global recovery vs placebo at 90 days in ICTUS | None on current evidence | Not established by definitive trial |
Free cytidine as a standalone nootropic (the marketing claim) Mixed Evidence | No reliable clinical-trial evidence in humans | None established by clinical evidence | Not established |
Cognitive impairment (vascular type, via citicoline)
- Effect
- Modest pooled effect favoring citicoline 500–2000 mg/day for 6+ months in vascular cognitive impairment
- Best fit
- Adults with mild vascular cognitive impairment exploring citicoline alongside vascular risk-factor management
- Time
- 6+ months in vascular cognitive impairment trials
Attention and focus in healthy adults (via citicoline)
- Effect
- Small attention-task improvement at 250–500 mg citicoline daily over 4 weeks
- Best fit
- Adults experimenting with citicoline for focus alongside sleep, caffeine, and other established strategies
- Time
- Weeks
Acute ischemic stroke recovery (via citicoline)
- Effect
- No significant benefit on global recovery vs placebo at 90 days in ICTUS
- Best fit
- None on current evidence
- Time
- Not established by definitive trial
Free cytidine as a standalone nootropic (the marketing claim)
- Effect
- No reliable clinical-trial evidence in humans
- Best fit
- None established by clinical evidence
- Time
- Not established
Evidence for 4 uses
AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.
Cognitive impairment (vascular type, via citicoline)
Supplement benefitSecades 2016 meta-analysis of citicoline (CDP-choline, the bioavailable cytidine-delivering form) showed modest pooled benefit for age-related and vascular cognitive impairment at 500–2000 mg/day over 6+ months. Effect sizes are small; trials are heterogeneous. The signal is real but modest and is specifically for citicoline, NOT for free cytidine supplements.
Bottom line: If you want the cognition signal, take citicoline (CDP-choline) — not standalone cytidine.
Attention and focus in healthy adults (via citicoline)
Supplement benefitMcGlade 2012 (n=75 adolescent females, 28 days, Cognizin citicoline 250/500 mg) showed modest attention-task improvements vs placebo. Industry-funded; small. Replication in independent labs is limited. Not specific to free cytidine.
Bottom line: Modest signal for citicoline. Free cytidine doesn't have this evidence.
Acute ischemic stroke recovery (via citicoline)
Supplement benefitThe ICTUS trial (Lancet 2012, n=2298, the largest stroke-recovery RCT of citicoline) was negative on the primary global-recovery endpoint at 90 days. Earlier smaller trials had hinted at benefit, but the definitive trial did not confirm it. Citicoline is no longer recommended in major stroke guidelines for acute treatment.
Bottom line: Stroke recovery: not supported. This is one of the largest failed neuroprotective-supplement trials in modern stroke research.
Evidence is mixed
Earlier smaller RCTs and meta-analyses hinted at benefit; the definitive large ICTUS trial (2012) was negative. The current weight of evidence does NOT support citicoline for acute stroke recovery.
Free cytidine as a standalone nootropic (the marketing claim)
Mechanism onlyStandalone oral cytidine supplements are sold as cognitive enhancers. The pharmacology argues against this: in humans, oral cytidine is largely deaminated to uridine in the gut before reaching circulation (Cansev 2006). Plasma cytidine rises minimally; plasma uridine rises substantially. There are no high-quality independent RCTs of free cytidine as a cognitive supplement in humans. Marketing claims rest on rodent data (where deamination is slower) and on extrapolation from citicoline trials.
Bottom line: Skip free cytidine. If you want the brain effect, buy citicoline (CDP-choline / Cognizin) or uridine, both of which actually circulate after oral intake.
How it works
How to take it
What to track
Bottom line: If you want the brain effects, take citicoline (Cognizin), 250–500 mg/day. Free cytidine standalone is not the bioavailable form in humans.
4 commercial forms
Compare the main delivery options and what they’re best suited for.
Citicoline (CDP-choline / Cognizin)
Bioavailable, studied formCytidine 5'-diphosphocholine. Hydrolyzed in the intestine to cytidine + choline, then resynthesized to CDP-choline systemically. THIS is the form with clinical-trial evidence (Secades 2016 meta-analysis, McGlade 2012 attention trial, ICTUS 2012 stroke trial). Cognizin (Kyowa Hakko) is the branded version used in most studies.
Well absorbed; delivers both cytidine arm and choline arm. The practical clinical form.
Free cytidine (capsules)
Pharmacokinetically inferiorStandalone cytidine sold as a nootropic. Orally administered cytidine is largely deaminated to uridine by intestinal cytidine deaminase before reaching circulation in humans. Free cytidine is therefore an indirect uridine delivery vehicle, not a cytidine delivery vehicle.
Poor — most converts to uridine in the gut.
Cytidine + uridine combo (Cognitex-style stacks)
Hard to attributeMulti-ingredient stacks adding cytidine, uridine, choline, and B vitamins. Reasonable concept (multiple pathway inputs) but no individual-ingredient evidence.
Variable; attribution to any single ingredient is impossible.
Uridine monophosphate (UMP)
Cross-referenceIf the goal is the cytidine/uridine arm of the Kennedy pathway, oral uridine monophosphate has more direct human pharmacokinetic data than free cytidine. See the Uridine page for details.
Better than free cytidine for raising plasma uridine; clinical evidence still modest.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Cytidine standalone has limited long-term human safety data. Citicoline has been studied at up to 2000 mg/day for 6 weeks (ICTUS trial) without major safety signals.
Theoretical interaction with caffeine, theophylline, or other adenosine-pathway agents (related nucleosides). No documented adverse events but caution if stacking nootropics.
Who should avoid it
- Pregnant or breastfeeding individuals — safety data are limited.
- Children — no established pediatric indication.
- People expecting acute stroke benefit — citicoline failed its definitive trial (ICTUS 2012). Do not substitute for guideline-based stroke care.
Pregnancy & breastfeeding
Avoid free cytidine and citicoline supplements during pregnancy and breastfeeding — safety data are limited. Routine prenatal vitamins are sufficient for choline/folate/methyl-donor needs in pregnancy.
Bottom line: Side-effect profile is mild. The bigger 'safety' message is matching the form to the goal: pick citicoline if you want the cognition signal, and don't substitute either for evidence-based stroke or dementia care.
Interactions
Some small studies of citicoline as a levodopa adjunct in Parkinson's. Effect inconclusive; coordinate with neurologist before stacking.
Combined wakefulness effects can compound jitteriness or insomnia in sensitive individuals. Dose earlier in the day.
Citicoline ultimately delivers choline; theoretical opposition to anticholinergic medications. Clinical significance unclear at usual doses.
Food sources
| Food | Amount | %DV |
|---|---|---|
| Beer (yeast-derived nucleotides) | Not standardized — small amounts in unfiltered beer | — |
| Organ meats (liver, pancreas) | Variable — purine/pyrimidine-rich | — |
| Fish roe | Variable — nucleotide-rich | — |
| Breast milk (infant nutrition) | Variable — pyrimidine nucleotides part of conditionally essential infant supply | — |
Beer (yeast-derived nucleotides)
- Amount
- Not standardized — small amounts in unfiltered beer
- %DV
- —
Organ meats (liver, pancreas)
- Amount
- Variable — purine/pyrimidine-rich
- %DV
- —
Fish roe
- Amount
- Variable — nucleotide-rich
- %DV
- —
Breast milk (infant nutrition)
- Amount
- Variable — pyrimidine nucleotides part of conditionally essential infant supply
- %DV
- —
Choosing a product
What to look for on the label — and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Is cytidine the same as citicoline?⌄
No. Citicoline (CDP-choline) is a larger molecule that contains cytidine plus choline. They are related but not identical.
Does cytidine cross the blood-brain barrier?⌄
In humans, ingested cytidine is largely converted to uridine, which enters the brain and supports phospholipid synthesis.
References by claim
Cognitive impairment (vascular type, via citicoline)
Free cytidine as a standalone nootropic (the marketing claim)
Wurtman et al., 2000 — PubMed — Journal of Cellular Biochemistry (2000) link
Acute ischemic stroke recovery (via citicoline)
Dávalos et al., 2012 (ICTUS trial) — PubMed — Lancet (2012) link
Attention and focus in healthy adults (via citicoline)
McGlade et al., 2012 — PMC — Food and Nutrition Sciences (2012) link
Track Cytidine with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.
Coming to App StoreDisclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.